Friday November 27 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Adrenocortical Hyperfunction

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Adrenocortical Hyperfunction:

Pubmed Logo
Management of endocrine manifestations and the use of mitotane as a chemotherapeutic agent for adrenocortical carcinoma.
Adrenal cortical carcinoma (ACC) is a rare malignancy in which patients...
5th November, 2009
Medical Oncology Branch, Center for Cancer Research, National Cancer J Clin Oncol. 2009 Sep 20;27(27):4619-29. Epub 2009 Aug 10.
DOI Direct Link
Elevations in sex hormones in dogs with sudden acquired retinal degeneration syndrome (SARDS).
Dogs diagnosed with sudden acquired retinal degeneration syndrome (SARDS)...
31st October, 2009
Department of Veterinary Clinical Sciences, School of Veterinary Medicine, J Am Anim Hosp Assoc. 2009 Sep-Oct;45(5):207-14.
[Hyperprogesteronism due to bilateral adrenal carcinomas in a cat with diabetes mellitus]
An 8 year old male castrated Russian Blue cat with polyuria, polydipsia,...
23rd October, 2009
Klinik fur Kleintiermedizin der Universitat Zurich. Schweiz Arch Tierheilkd. 2009 Sep;151(9):437-42.
DOI Direct Link
[Cushing's syndrome: special issues]
The present article reviews: Corticotrophin (ACTH) independent bilateral...
6th October, 2009
Servicio de Endocrinologia, Hospital de Navarra, Pamplona, Navarra, Spain. Endocrinol Nutr. 2009 May;56(5):251-61. Epub 2009 Jul 1.
DOI Direct Link
Transfer of Metyrapone and Its Metabolite, rac-Metyrapol, Into Breast Milk.
Metyrapone, an inhibitor of corticosteroid biosynthesis, is used in the...
18th September, 2009
J Hum Lact. 2009 Sep 16.
DOI Direct Link

View more research publications.

BioNews Results for Adrenocortical Hyperfunction:

RSS Logo
BioPortfolio Logo
The Glucocorticoid Receptor Is Overexpressed in Malignant Adrenocortical Tumors
MDLinx:  Oct 15 2009 10:42AM Matching: adrenocortical
OSI Pharmaceuticals Initiates Phase III Registration-Oriented Study for OSI-906 in Adrenocortical Carcinoma an
Business Wire via Yahoo!:  Sep 3 2009 8:15PM Matching: adrenocortical

Adrenocortical Hyperfunction Clinical Trials:

Clinical Trials Logo
Heart Disease Risk Factors in Major Depression

Adrenocortical Hyperfunction Patents:

USPTO Logo
US Patent No.Title
7358074 Human phosphatase RET31, and variants thereof
7153678 Polynucleotides encoding the novel human phosphatase, RET31, and variants thereof
4029776 Therapeutic composition and method of use thereof

BioPortfolio Ltd. offers e-mail and postal lists for Adrenocortical Hyperfunction scientists - we have details of around 220 individuals working on Adrenocortical Hyperfunction .


This page has been viewed 408 times
Recent Search Terms used to find this page: adrenocortical hyperfunction | adrenocortical hyperfunction | Adrenocortical hyperfunction | adrenocortical hyperfunction | Adrenocortical Hyperfunction | adrenocortical hyperfunction | adrenocortical hyperfunction | Adrenocortical hyperfunction | adrenocortical hyperfunction | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Adrenocortical Hyperfunction across BioPortfolio, or for Adrenocortical Hyperfunction Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.